← Back to Search

Digital Community for HIV & Hepatitis C Prevention

N/A
Recruiting
Led By Dolores Albarracin, PhD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Under the age of 18
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, session 2 [experimental condition only], immediate follow-up (3 weeks), 3 months, 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial studies how to reduce HIV & HCV infections in areas with high risk due to injection drug use.

Who is the study for?
This trial is for adults living in specific high-risk areas of Appalachia and the Midwest, where there's a concern about HIV and Hepatitis C due to injection drug use. It includes those who have used illicit substances within the last month as well as those who haven't in the past year.
What is being tested?
The study tests a 'Virtual Community Intervention' against the usual health practices (Standard of Care) to see if it can improve health outcomes related to infectious diseases like HIV and Hepatitis C in rural communities.
What are the potential side effects?
Since this intervention is non-medical and involves digital community support, direct physical side effects are not expected. However, participants may experience stress or discomfort from discussing personal health issues online.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am younger than 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, session 2 [experimental condition only], immediate follow-up (3 weeks), 3 months, 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, session 2 [experimental condition only], immediate follow-up (3 weeks), 3 months, 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
HIV/HCV Prevention
HIV/HCV Testing and Treatment
Overdose Prevention
+3 more
Secondary study objectives
Policy Support
Substance Use
Syringe Use
Other study objectives
Contributions to town, neighborhood, community of friends, church, or other groups
Discovering new organizations, groups, or activities
Using Naloxone on Someone

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Virtual Community InterventionExperimental Treatment1 Intervention
Participants will participate in an online community with structured sessions as well as the ability to communicate freely with others.
Group II: Standard of CareActive Control1 Intervention
Participants will be exposed to what's disseminated within their communities

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,079 Previous Clinical Trials
42,721,021 Total Patients Enrolled
West Virginia UniversityOTHER
185 Previous Clinical Trials
64,173 Total Patients Enrolled
Dolores Albarracin, PhDPrincipal InvestigatorUniv. of Pennsylvania
1 Previous Clinical Trials
722 Total Patients Enrolled

Media Library

Virtual Community Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05363865 — N/A
Human Immunodeficiency Virus Infection Research Study Groups: Virtual Community Intervention, Standard of Care
Human Immunodeficiency Virus Infection Clinical Trial 2023: Virtual Community Intervention Highlights & Side Effects. Trial Name: NCT05363865 — N/A
Virtual Community Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05363865 — N/A
~33 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top